Endocrine effects of chronic intraventricular administration of delta9-tetrahydrocannabinol to prepuberal and adult male rats.
D000311:Adrenal Glands / Q000033:anatomy & histology; D000367:Age Factors; D000818:Animals; D001835:Body Weight / Q000187:drug effects; D001921:Brain / Q000033:anatomy & histology / Q000187:drug effects* / Q000378:metabolism; D002188:Cannabis / Q000494:pharmacology*; D003345:Corticosterone / Q000097:blood; D004298:Dopamine / Q000378:metabolism; D013759:Dronabinol / Q000008:administration & dosage / Q000494:pharmacology*; D005640:Follicle Stimulating Hormone / Q000378:metabolism; D013006:Growth Hormone / Q000378:metabolism; D007276:Injections, Intraventricular; D007986:Luteinizing Hormone / Q000378:metabolism; D008297:Male; D009638:Norepinephrine / Q000378:metabolism; D009929:Organ Size / Q000187:drug effects; D010902:Pituitary Gland / Q000033:anatomy & histology / Q000378:metabolism; D011388:Prolactin / Q000378:metabolism; D011467:Prostate / Q000033:anatomy & histology; D051381:Rats; D012701:Serotonin / Q000378:metabolism; D013737:Testis / Q000033:anatomy & histology
D012701:Serotonin; D013759:Dronabinol; D011388:Prolactin; D007986:Luteinizing Hormone; D005640:Follicle Stimulating Hormone; D013006:Growth Hormone; D004298:Dopamine; D003345:Corticosterone; D009638:Norepinephrine